• SEP 06 2015

    Oncoceutics to Present at the BIO Investor Forum

    Oncoceutics has been selected to present on the Discovery Track at the 14th Annual Bio Investor Forum, which will take place on October 20-21, 2015, in San Francisco. Oncoceutics is delighted to have been chosen to take part in the BIO Investor Forum, which is designed to “explore investment trends and opportunities in life sciences, with a

    • MAY 30 2015

    First-in-Man ONC201 Trial to be Presented at 2015 ASCO Meeting

    Dr. Mark Stein, Principal Investigator of the first-in-man trial will discuss the first-in-human dose escalation study of oral ONC201 in advanced solid tumors at the 2015 ASCO Annual Meeting.  

    • MAY 30 2015

    ASCO Annual Meeting 2015

    Poster presented by Mark Stein, MD, Prinicpal Investigator of the first-in-man Trial, at the 2015 ASCO Annual Meeting in Chicago IL.

    • MAY 29 2015

    Brain Tumor Biotech Summit 2015

    Joshua Allen, PhD, VP Research & Development, talks about the potential of ONC201 to treat glioblastoma multiforme at the Brain Tumor Biotech Summit 2015 in New York City on May 29 2015.